Donaldson Reports Record Q3 Sales & Earnings, Narrows FY26 Guidance
DCI sits 22% above its 52-week low of $67.705 on elevated volume (2.6× avg).
Summary
Donaldson Company reported record third-quarter sales and adjusted earnings per share, exceeding analyst estimates, and narrowed its full-year fiscal 2026 guidance, projecting record sales and adjusted EPS.
Key Events · Earnings and Guidance · DCI
-
Record Q3 Financial Performance
Sales of $995.1 million (up 5.8%) and adjusted EPS of $1.06 (up 7.1%) surpassed analyst expectations for the quarter ended April 30, 2026.
-
Strong Operating Margin
The company achieved an all-time high adjusted operating margin of 16.6% in the third quarter.
-
Updated Fiscal 2026 Guidance
Donaldson narrowed its full-year guidance, projecting record sales and adjusted EPS, with increased organic sales and Life Sciences segment growth expectations, though adjusted operating margin guidance was slightly lowered.
-
Facet Acquisition Closed
The $829 million Facet Filtration acquisition, previously announced, officially closed on May 4, 2026, and is expected to be margin-accretive while causing a slight $0.03 EPS dilution for fiscal 2026.
Analysis · DCI · Technology
This 8-K confirms strong financial performance for Donaldson, with Q3 results exceeding expectations for both sales and adjusted EPS. The updated full-year guidance, while mixed in some areas, generally points to continued growth and record outcomes, reinforcing a positive outlook. The formal closing of the Facet acquisition also provides clarity on a significant strategic move.
At the time of this filing, DCI was trading at $82.28 on NYSE in the Technology sector, with a market capitalization of approximately $9.5B. The 52-week trading range was $67.71 to $112.84. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.